Please assess the completion status of the following clinical trial:

Trial Title: Continuous Subcutaneous Infusion of Pramlintide and Insulin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~These children will be subjects of the Texas Children's Hospital Diabetes Care Center. The subjects must be~1. 13-22 years of age at the time of enrollment.~2. Have been diagnosed with diabetes for at least 1 year and in good control (HbA1C less than or equal to 8.5%).~3. Be on continuous subcutaneous insulin infusion using an insulin pump.~4. Subjects must be otherwise healthy except for their T1DM and treated hypothyroidism.~5. Menstruating women must have a negative pregnancy test.~6. Hemoglobin equal to or greater than 12 g/dL before each study.~7. Weight more than 44 kg. -~Exclusion Criteria:~1. Age greater than 23 years or less than 13 years at the time of study~2. Any chronic disease: leukemia, asthma, inflammatory bowel disease, cystic fibrosis, juvenile rheumatoid arthritis, etc or on treatment that might directly or indirectly affect glucose homeostasis, except for diabetes and hypothyroidism stable on medications~3. Anemia (hemoglobin less than 12mg/dl)~4. Lack of a supportive family environment~5. Positive pregnancy test in menstruating young women~6. Evidence or history of chemical abuse~7. Hgb A1C greater than 8.5 % in a diabetic subject~8. BMI \> 90 % tile for age or \< 10 % tile for age~9. Weight less than 44 kg. -

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 22 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).